Chain Drug Review and Kearney recently assembled a group of leading pharmacy operators and other retailers, physicians, payers, public officials, and policy experts for the second-annual Health Equity Summit in Chicago. This installment of Video Forum is the first in a series that will present highlights from the event. Here are excerpts from remarks by keynote speaker Kristin Williams, executive vice president and chief health strategy and policy officer at Hy-Vee, and Kearney partner Dominique Harris, who served as host for the event.
Video Forum: Health Equity Summit, Part 1
Chain Drug Review and Kearney recently assembled a group of leading pharmacy operators and other retailers, physicians, payers, public officials, and policy experts for the second-annual Health Equity Summit in Chicago.
Latest
Nine of the largest pharma companies ink deals with Trump to lower drug prices
The agreements reduce prices on drugs that treat numerous costly and chronic conditions.
Merck and U.S. government partner to expand access to medicines and reduce costs for Americans
The company has committed more than $70 billion in U.S. investments to boost domestic production and innovation.
Google Trends looks at 2026 wellness shifts
Google Trends analysis revealed that new types of health-related searches emerged in the second half of 2025 and will continue into next year.
CRN appoints 2026 board leaders amid supplement regulation pressure
The Council for Responsible Nutrition announced its 2026 Board of Directors as it gears up for increased regulation and legislation.